According to FutureWise analysis the market for dialysis concentrates is expected to reach US$ 4.75 billion by 2031 at a CAGR of 5.6%.
Dialysis concentrates are essential fluids made up of purified water, glucose, and carefully balanced electrolytes. Their composition closely mirrors the natural electrolyte levels found in our blood, with the exception of potassium and the buffering agents. Customized to meet individual patient needs, dialysis fluid plays a crucial role in regulating electrolyte and acid-base balance while effectively eliminating metabolic waste.
In the world of hemodialysis, there are primarily two types of concentrates: bicarbonate (base) and acid. These concentrates mix with treated water to create the vital dialysis fluid, or dialysate, that facilitates the hemodialysis process. Once the acid concentrates are blended with water and bicarbonate, the result is a tailored dialysate that can include up to three buffering components, adjusted based on the specific acid concentrate used.
The impact of chronic kidney disease is staggering, affecting around 10% of the global population. Every year, over 2 million people undergo dialysis, with a significant 80% of those procedures taking place in the US, Germany, Japan, Brazil, and Italy. The remaining 20% occurs in other countries, highlighting a growing demand for dialysis services, especially in middle-income nations.
The increasing rates of chronic kidney disorders are driving significant market growth, as more patients seek effective management solutions for their conditions. As reported by the WHO, 2.6 million individuals received dialysis worldwide in 2010, and this number is expected to double by 2030. As financial pressures mount, innovative treatment strategies are being developed to ensure better management of kidney diseases, with dialysis standing out as a highly effective option for patients in need.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=191%20&type=requestsample
Dialysis Concentrates Market Segmentation:
By Type
- Acid Concentrates
- Bicarbonate Concentrates
- Perioneal Dialysis Fluid
By Application
- Hemodialysis Dialysis
- Peritoneal Dialysis
By End User
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
- Other End-Users
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Competitive Landscape in the Dialysis Concentrates Market:
- B. Braun Melsungen AG
- Nipro Renal Solutions
- Fresenius Medical Care
- Baxter
- Medites Pharma
- Dialife
- Hemoclean
- Farmasol
- Rockwell Medical
- Asahi Kasei Medical Co. Ltd
- Sandu Pharmaceuticals Limited
- NIKKISO CO., LTD
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=191&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Dialysis Concentrates Market By Type, By Application, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
